Absolute abundances and affinity states of dopamine receptors in mammalian brain: A review

The abundances of dopamine (DA) D1 and D2 receptors have been assayed with radioligands in membrane preparations and by autoradiography in vitro, and also in living brain using positron emission tomography (PET). This review compares the saturation binding parameters (Bmax and KD) obtained in striatum by these several methods, and in different species. Some uncertainty in quantitation is derived from the incomplete specificities of commonly used ligands, especially Sch 23,390 for D1 sites and spiperone for D2‐like sites. In striatal membrane preparations, the D1 Bmax ranges from 10 to 139 pmol g−1 tissue, whereas the D2 Bmax ranges from 8 to 42 pmol g−1 tissue. Receptor concentrations in human material, despite the more extended post mortem interval, are roughly similar to those reported in rodent and nonhuman primate. Estimates of Bmax by quantitative autoradiography are generally five times higher than corresponding results for similar ligands in membrane preparations. The saturation binding parameters in living striatum have been estimated by serial PET studies with ligands over a range of specific activities. The few PET estimates of D1 Bmax, (40–80 pmol g−1) and numerous PET estimates of D2 Bmax (20–40 pmol g−1) are in general agreement with membrane estimates, but fall far short of the mean of autoradiographic results in vitro. Apparent affinities for D1 and D2 ligands in vivo are typically 10 times lower than for corresponding in vitro studies, presumably because the unbound ligand concentration is not corrected for the free fraction in living brain tissue. The disparate Bmax results by method suggest the presence of a large reservoir or reserve of D1 and D2 receptors in intact brain sections, which are unavailable to PET ligands in vivo, and which may be lost during the preparation of washed membranes. A subset of receptors existing in a high affinity state for agonists is detected in washed membrane preparations, in which the coupling to intracellular G‐proteins may have become artificially limiting. However, in most PET and autoradiographic studies in vitro, agonist and antagonist ligands have similar Bmax. Discrepancies in the literature highlight the need for a better understanding of affinity states in vivo and trafficking of G‐protein coupled receptors between plasma membrane and intracellular compartments. Synapse, 2011. © 2011 Wiley‐Liss, Inc.

[1]  J. R.,et al.  Quantitative analysis , 1892, Nature.

[2]  Michael,et al.  Dopamine receptor sites in the anterior pituitary. , 1979, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[3]  D. Sibley,et al.  Anterior pituitary dopamine receptors. Demonstration of interconvertible high and low affinity states of the D-2 dopamine receptor. , 1982, The Journal of biological chemistry.

[4]  M. Titeler,et al.  [3H]N-propylapomorphine and [3H]spiperone binding in brain indicate two states of the D2-dopamine receptor. , 1982, European journal of pharmacology.

[5]  S. Lazareno,et al.  Selective labelling of dopamine (D2) receptors in rat striatum by [3H]domperidone but not by [3H]spiperone. , 1982, European journal of pharmacology.

[6]  C. Marsden,et al.  Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration. , 1983, Biochemical pharmacology.

[7]  P. Jenner,et al.  Differential anatomical location of [3H]‐N,n‐propylnorapomorphine and [3 H]‐spiperone binding sites in the striatum and substantia nigra of the rat , 1983, British journal of pharmacology.

[8]  M. Dubocovich,et al.  Comparison of dopamine receptor sites labeled by [3H]-S-sulpiride and [3H]-spiperone in striatum. , 1983, The Journal of pharmacology and experimental therapeutics.

[9]  H. Feldman Statistical limits in Scatchard analysis. , 1983, The Journal of biological chemistry.

[10]  D. Sibley,et al.  Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding state. , 1983, Molecular Pharmacology.

[11]  I. Creese,et al.  Interactions of agonists with D-2 dopamine receptors: evidence for a single receptor population existing in multiple agonist affinity-states in rat striatal membranes. , 1984, Biochemical pharmacology.

[12]  C. Altar,et al.  Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: Plasticity of neostriatal dopamine receptors after nigrostriatal injury , 1984, Brain Research.

[13]  M. Mintun,et al.  A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography , 1984, Annals of neurology.

[14]  J. Korf,et al.  In vivo binding of N-n-propylnorapomorphine in the rat striatum: quantification after lesions produced by kainate, 6-hydroxydopamine and decortication. , 1984, European journal of pharmacology.

[15]  I. Creese,et al.  Interactions of dopamine agonists with brain D1 receptors labeled by 3H-antagonists. Evidence for the presence of high and low affinity agonist-binding states. , 1985, Molecular pharmacology.

[16]  D. Kendall,et al.  Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation. , 1985, European journal of pharmacology.

[17]  I. Creese,et al.  Interactions of dopaminergic agonists and antagonists with dopaminergic D3 binding sites in rat striatum. Evidence that [3H]dopamine can label a high affinity agonist-binding state of the D1 dopamine receptor. , 1985, Molecular pharmacology.

[18]  I. Creese,et al.  Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum. , 1986, European journal of pharmacology.

[19]  A. Friedhoff,et al.  Receptor reserve at striatal dopamine autoreceptors: implications for selectivity of dopamine agonists. , 1986, European journal of pharmacology.

[20]  J. Korf,et al.  Tracer and maximal specific binding of tritiated spiperone or N-n-propylnorapomorphine to quantify dopamine receptors in rat brain regions in vivo. , 1986, Life sciences.

[21]  G. Pearlson,et al.  Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. , 1986, Science.

[22]  G. Wooten,et al.  Dopamine denervation does not alter in vivo 3H‐spiperone binding in rat striatum: Implications for external imaging of dopamine receptors in Parkinson's disease , 1986, Annals of neurology.

[23]  E. Richfield,et al.  Properties of D2 dopamine receptor autoradiography: High percentage of high-affinity agonist sites and increased nucleotide sensitivity in tissue sections , 1986, Brain Research.

[24]  M. Raichle,et al.  In vitro or in vivo receptor binding: Where does the truth lie? , 1986, Annals of neurology.

[25]  G. Sedvall,et al.  Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.

[26]  H. Hall,et al.  Comparisons between the in vitro binding of two substituted benzamides and two butyrophenones to dopamine-D2 receptors in the rat striatum. , 2009, Acta pharmacologica et toxicologica.

[27]  P. Molinoff,et al.  Quantitative autoradiographic localization of the D1 and D2 subtypes of dopamine receptors in rat brain , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[28]  J M Links,et al.  3H-3-N-methylspiperone labels D2 dopamine receptors in basal ganglia and S2 serotonin receptors in cerebral cortex , 1986, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[29]  Philip Seeman,et al.  Human brain dopamine receptors in children and aging adults , 1987, Synapse.

[30]  P. Seeman,et al.  The absolute density of neurotransmitter receptors in the brain. Example for dopamine receptors. , 1987, Journal of pharmacological methods.

[31]  O. Gredal,et al.  In Situ Molecular Size of Agonist Dopamine D‐2 Binding Sites in Rat Striatum , 1987, Journal of neurochemistry.

[32]  J. Bennett,et al.  [3H]Spiperone binds selectively to rat striatal D2 dopamine receptors in vivo: a kinetic and pharmacological analysis , 1987, Brain Research.

[33]  E. Richfield,et al.  Comparative distribution of dopamine D‐1 and D‐2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys , 1987, The Journal of comparative neurology.

[34]  A. Horita,et al.  Age-related decreases in dopamine receptors in the caudate nucleus and putamen of the rhesus monkey (Macaca mulatta) , 1987, Neurobiology of Aging.

[35]  H. Hall,et al.  Effects of temperature on the in vitro binding of 3H-raclopride to rat striatal dopamine-D2 receptors. , 1988, Pharmacology & toxicology.

[36]  M. Goldstein,et al.  Receptor reserve at striatal dopamine receptors modulating the release of [3H]dopamine. , 1988, European journal of pharmacology.

[37]  M. Phelps,et al.  In vivo [3H]Spiperone Binding: Evidence for Accumulation in Corpus Striatum by Agonist-Mediated Receptor Internalization , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[38]  R. M. Beckstead,et al.  Distribution of D1 and D2 dopamine receptors in the basal ganglia of the cat determined by quantitative autoradiography , 1988, The Journal of comparative neurology.

[39]  M. Terai,et al.  Comparison of [3H]YM-09151-2 with [3H]spiperone and [3H]raclopride for dopamine d-2 receptor binding to rat striatum. , 1989, European journal of pharmacology.

[40]  M. Gnegy,et al.  Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site. , 1989, Molecular pharmacology.

[41]  H. Rosengarten,et al.  A full repetitive jaw movement response after 70% depletion of caudate D1 receptors , 1989, Pharmacology Biochemistry and Behavior.

[42]  D. Sibley,et al.  Chronic estrogen treatment promotes a functional uncoupling of the D2 dopamine receptor in rat anterior pituitary gland. , 1989, Endocrinology.

[43]  C. Halldin,et al.  Comparison of the In Vitro Receptor Binding Properties of N‐[3H]Methylspiperone and [3H]Raclopride to Rat and Human Brain Membranes , 1990, Journal of neurochemistry.

[44]  S. Boyce,et al.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. II. Unilateral intra-carotid infusion of MPTP in the monkey (Macaca fascicularis) , 1990, Brain Research.

[45]  T. Reader,et al.  Effects of monovalent cations on neostriatal dopamine D2 receptors labeled with [3H]raclopride. , 1990, Biochemical pharmacology.

[46]  A. Crossman,et al.  Autoradiographic studies in animal models of hemi-parkinsonism reveal dopamine D2 but not D1 receptor supersensitivity. I. 6-OHDA lesions of ascending mesencephalic dopaminergic pathways in the rat , 1990, Brain Research.

[47]  G. Biggio,et al.  Selective unilateral inactivation of striatal D1 and D2 dopamine receptor subtypes by EEDQ: turning behavior elicited by D2 dopamine receptor agonists , 1990, Brain Research.

[48]  Päivi Marjamäki,et al.  Age-dependent decline in human brain dopamine D1 and D2 receptors , 1990, Brain Research.

[49]  P. Molinoff,et al.  Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. , 1991, Brain research. Developmental brain research.

[50]  Päivi Marjamäki,et al.  A post-mortem study on striatal dopamine receptors in Parkinson's disease , 1991, Brain Research.

[51]  D. Wong,et al.  Effects of endogenous dopamine on kinetics of [3H]N‐methylspiperone and [3H]raclopride binding in the rat brain , 1991, Synapse.

[52]  D. Grigoriadis,et al.  Characterization of [3H]quinpirole binding to D2-like dopamine receptors in rat brain. , 1992, The Journal of pharmacology and experimental therapeutics.

[53]  R. Mcquade,et al.  Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates , 1992, Pharmacology Biochemistry and Behavior.

[54]  J. Glowinski,et al.  Autoradiographic identification of D1 dopamine receptors labelled with [3H]dopamine: Distribution, regulation and relationship to coupling , 1992, Neuroscience.

[55]  P. Hedlund,et al.  Chronic nicotine treatment decreases dopamine D2 agonist binding in the rat basal ganglia. , 1992, Neuroreport.

[56]  M. Sambrook,et al.  Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism , 1993, Brain Research.

[57]  U Ruotsalainen,et al.  Decrease in Human Striatal Dopamine D2 Receptor Density with Age: A PET Study with [11C]Raclopride , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[58]  D. Grigoriadis,et al.  [3H]quinpirole binding to putative D2 and D3 dopamine receptors in rat brain and pituitary gland: a quantitative autoradiographic study. , 1993, The Journal of pharmacology and experimental therapeutics.

[59]  P Seeman,et al.  Dopamine D2 receptors mapped in rat brain with [3H](+)PHNO , 1994, Synapse.

[60]  Christer Halldin,et al.  Distribution of D1- and D2-Dopamine Receptors, and Dopamine and Its Metabolites in the Human Brain , 1994, Neuropsychopharmacology.

[61]  C. Marsden,et al.  An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat , 1994, Neuropharmacology.

[62]  寺井 道夫 Comparison of [[3]H]YM-09151-2 with [[3]H]spiperone and [[3]H]raclopride for dopamine D-2 receptor binding to rat striatum , 1994 .

[63]  M. Knowles,et al.  Expression and pharmacological characterization of the human D3 dopamine receptor. , 1994, The Journal of pharmacology and experimental therapeutics.

[64]  L. Eriksson,et al.  No elevated D2 dopamine receptors in neuroleptic-naive schizophrenic patients revealed by positron emission tomography and [11C]N-methylspiperone , 1995, Psychiatry Research: Neuroimaging.

[65]  C. Halldin,et al.  Variability in D2‐dopamine receptor density and affinity: A PET study with [11C]raclopride in man , 1995, Synapse.

[66]  Ulla Ruotsalainen,et al.  Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson's disease: a PET study with [11C]raclopride , 1995, Journal of the Neurological Sciences.

[67]  P. Bédard,et al.  Effect of adding the D-1 agonist CY 208–243 to chronic bromocriptine treatment of MPTP-monkeys: Regional changes of brain dopamine receptors , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[68]  P. Hedlund,et al.  Effects of CGS 21680 in vivo on dopamine D2 agonist binding in the rat brain , 1995, Brain Research.

[69]  K. Fuxe,et al.  Cholecystokinin Octapeptide In Vitro and Ex Vivo Strongly Modulates Striatal Dopamine D2 Receptors in Rat Forebrain Sections , 1995, The European journal of neuroscience.

[70]  P. Strange,et al.  [3H]Nemonapride and [3H]Spiperone Label Equivalent Numbers of D2 and D3 Dopamine Receptors in a Range of Tissues and Under Different Conditions , 1995, Journal of neurochemistry.

[71]  Lars Farde,et al.  Autoradiographic localisation of D3-dopamine receptors in the human brain using the selective D3-dopamine receptor agonist (+)-[3H]PD 128907 , 1996, Psychopharmacology.

[72]  E. Jerning,et al.  Critical reevaluation of spiperone and benzamide binding to dopamine D2 receptors: evidence for identical binding sites. , 1996, European journal of pharmacology.

[73]  Luciana Giardino,et al.  Right-left asymmetry of D1- and D2-receptor density is lost in the basal ganglia of old rats , 1996, Brain Research.

[74]  S. Houle,et al.  In vivo binding of [11C]SKF 75670 and [11C]SKF 82957 in rat brain: two dopamine D-1 receptor agonist ligands. , 1996, Life sciences.

[75]  K. Kameyama,et al.  Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells. , 1996, Molecular pharmacology.

[76]  S. Nishiyama,et al.  Effects of Binge Pattern Cocaine Administration on Dopamine D1 and D2 Receptors in the Rat Brain: AnIn Vivo Study Using Positron Emission Tomography , 1996, The Journal of Neuroscience.

[77]  T. Reader,et al.  Alterations in the turnover rate of dopamine D1 but not D2 receptors in the adult rat neostriatum after a neonatal dopamine denervation , 1997, Neurochemistry International.

[78]  A. Westlind-Danielsson,et al.  Dopamine D2 receptor upregulation in rat neostriatum following in vivo infusion of forskolin , 1997, Neuroreport.

[79]  J. Tallman,et al.  II. Localization and characterization of dopamine D4 binding sites in rat and human brain by use of the novel, D4 receptor-selective ligand [3H]NGD 94-1. , 1997, The Journal of pharmacology and experimental therapeutics.

[80]  S. Potkin,et al.  Differential labeling of dopamine and sigma sites by [3H]nemonapride and [3H]raclopride in postmortem human brains , 1997, Brain Research.

[81]  G. Pearlson,et al.  Quantification of Neuroreceptors in the Living Human Brain: IV. Effect of Aging and Elevations of D2-Like Receptors in Schizophrenia and Bipolar Illness , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[82]  Christer Halldin,et al.  Effect of reserpine‐induced depletion of synaptic dopamine on [11C]Raclopride binding to D2‐dopamine receptors in the monkey brain , 1997, Synapse.

[83]  W C Eckelman,et al.  Kinetic Modeling of [11C]Raclopride: Combined PET-Microdialysis Studies , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[84]  D. Copolov,et al.  The Binding of Both [3H]Nemonapride and [3H]Raclopride Is Increased in Schizophrenia , 1997, Biological Psychiatry.

[85]  P B Hoffer,et al.  Microdialysis and SPECT measurements of amphetamine‐induced dopamine release in nonhuman primates , 1997, Synapse.

[86]  M. Herrera-Marschitz,et al.  Perinatal Asphyxia Induces Long-Term Changes in Dopamine D1, D2, and D3Receptor Binding in the Rat Brain , 1997, Experimental Neurology.

[87]  I. Creese,et al.  Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs. , 1997, The Journal of pharmacology and experimental therapeutics.

[88]  M. Nader,et al.  Effect of cocaine self‐administration on striatal dopamine D1 receptors in rhesus monkeys , 1998, Synapse.

[89]  The effect of acute kainic acid treatment on dopamine D2 receptors in rat brain , 1998, Neuroscience Research.

[90]  J. Sergeant,et al.  Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD , 1998, Behavioural Brain Research.

[91]  M. Bergström,et al.  N-[11C]Methylspiperone PET, in contrast to [11C]raclopride, fails to detect D2 receptor occupancy by an atypical neuroleptic , 1998, Psychiatry Research: Neuroimaging.

[92]  F. J. White,et al.  Alterations in Dopamine Release But Not Dopamine Autoreceptor Function in Dopamine D3 Receptor Mutant Mice , 1998, The Journal of Neuroscience.

[93]  M. Nader,et al.  Effect of cocaine self‐administration on dopamine D2 receptors in rhesus monkeys , 1998, Synapse.

[94]  D. Hovda,et al.  Differences in D2 dopamine receptor binding in the neostriatum between cats hemidecorticated neonatally or in adulthood. , 1998, Brain research. Developmental brain research.

[95]  P. Seeman,et al.  Dopamine D2 receptor dimers in human and rat brain , 1998, FEBS letters.

[96]  Flügge,et al.  5HT1A‐Receptor Binding in the Brain of Cyclic and Ovariectomized Female Rats , 1999, Journal of neuroendocrinology.

[97]  Christer Halldin,et al.  A PET study of D1-like dopamine receptor ligand binding , 1999, Psychopharmacology.

[98]  R. Mailman,et al.  Developmental Regulation of the Dopamine D1 Receptor in Human Caudate and Putamen , 1999, Neuropsychopharmacology.

[99]  J. Joyce,et al.  Distribution of Dopamine D3 Receptor Expressing Neurons in the Human Forebrain: Comparison with D2 Receptor Expressing Neurons , 1999, Neuropsychopharmacology.

[100]  A. Gee,et al.  Discrepancies in apparent dopamine D2 receptor occupancy between 3H-raclopride and 3H-N-methylspiperone , 1999, Journal of Neural Transmission.

[101]  P. Bédard,et al.  Regulation by chronic treatment with cabergoline of dopamine D1 and D2 receptor levels and their expression in the striatum of Parkinsonian-monkeys , 2000, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[102]  V Kaasinen,et al.  Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[103]  O. Paulson,et al.  SPECT tracer [123I]IBZM has similar affinity to dopamine D2 and D3 receptors , 2000, Synapse.

[104]  R. Mailman,et al.  Quantification of D1B (D5) receptors in dopamine D1A receptor‐deficient mice , 2001, Synapse.

[105]  S. Kapur,et al.  Amphetamine‐sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges , 2002, Synapse.

[106]  S. Kapur,et al.  Dopamine D2 receptors internalize in their low-affinity state , 2002, Neuroreport.

[107]  J. Holden,et al.  Density and affinity of the dopamine D2 receptors in aged symptomatic and asymptomatic MPTP‐treated monkeys: PET studies with [11C]raclopride , 2002, Synapse.

[108]  Doris J. Doudet,et al.  In Vivo Receptor Assay with Multiple Ligand Concentrations: An Equilibrium Approach , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[109]  Albert Gjedde,et al.  Specific Binding of [11C]Raclopride and N-[3H]Propyl-Norapomorphine to Dopamine Receptors in Living Mouse Striatum: Occupancy by Endogenous Dopamine and Guanosine Triphosphate–Free G Protein , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[110]  M. Senda,et al.  Demonstration of competition between endogenous dopamine and [11C]raclopride binding in in vitro brain slices using a dynamic autoradiography technique , 2002, Synapse.

[111]  G. Sedvall,et al.  PET study of D(1) dopamine receptor binding in neuroleptic-naive patients with schizophrenia. , 2002, The American journal of psychiatry.

[112]  Doris J Doudet,et al.  Sequential Versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]raclopride: Effect of Methamphetamine , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[113]  P. Seeman,et al.  Dopamine displaces [3H]domperidone from high‐affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography , 2003, Synapse.

[114]  M. Beu,et al.  In vivo measurement of D2 receptor density and affinity for 18F-(3-N-methyl)benperidol in the rat striatum with a PET system for small laboratory animals. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[115]  E. Krause,et al.  Galpha(s) is palmitoylated at the N-terminal glycine. , 2003, The EMBO journal.

[116]  S. Kapur,et al.  In vivo evidence for dopamine-mediated internalization of D2-receptors after amphetamine: differential findings with [3H]raclopride versus [3H]spiperone. , 2003, Molecular pharmacology.

[117]  E. Krause,et al.  Gαs is palmitoylated at the N‐terminal glycine , 2003 .

[118]  P. Fletcher,et al.  Up-regulated dopamine D1 receptor binding can be detected in vivo following repeated SCH 23390, but not SKF 81297 or 6-hydroxydopamine, treatments. , 2003, European journal of pharmacology.

[119]  M. Beu,et al.  In Vivo Measurement of D 2 Receptor Density and Affinity for 18 F-( 3N-Methyl ) Benperidol in the Rat Striatum with a PET System for Small Laboratory Animals , 2003 .

[120]  P. Seeman,et al.  Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2 , 1985, Naunyn-Schmiedeberg's Archives of Pharmacology.

[121]  Albert Gjedde,et al.  MDMA‐evoked changes in [11C]raclopride and [11C]NMSP binding in living pig brain , 2004, Synapse.

[122]  D. Coward,et al.  Binding of 3H-spiperone and 3H-(−)-sulpiride to dopamine D2 receptors in rat striatal membranes: methodological considerations and demonstration of the identical nature of the binding sites for the two ligands , 1987, Naunyn-Schmiedeberg's Archives of Pharmacology.

[123]  Svante B. Ross,et al.  Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[124]  Sylvain Houle,et al.  Oral D‐amphetamine causes prolonged displacement of [11C]raclopride as measured by PET , 2004, Synapse.

[125]  S. Heales,et al.  Alterations in expression of dopamine receptors and neuropeptides in the striatum of GTP cyclohydrolase-deficient mice , 2004, Experimental Neurology.

[126]  Jogeshwar Mukherjee,et al.  Measuring the in Vivo Binding Parameters of [18F]-Fallypride in Monkeys Using a PET Multiple-Injection Protocol , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[127]  D. Jackson,et al.  Kinetic properties of the in vivo accumulation of 3H-(−)-N-n-propylnorapomorphine in mouse brain , 1989, Naunyn-Schmiedeberg's Archives of Pharmacology.

[128]  Rudie Kortekaas,et al.  In vivo Binding Behavior of Dopamine Receptor Agonist (+)−PD 128907 and Implications for the “Ceiling Effect” in Endogenous Competition Studies with [11C]Raclopride—a Positron Emission Tomography Study in Macaca mulatta , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[129]  Mark Slifstein,et al.  In vivo vulnerability to competition by endogenous dopamine: Comparison of the D2 receptor agonist radiotracer (–)‐N‐[11C]propyl‐norapomorphine ([11C]NPA) with the D2 receptor antagonist radiotracer [11C]‐raclopride , 2004, Synapse.

[130]  Sylvain Houle,et al.  Amphetamine pretreatment induces a change in both D2-Receptor density and apparent affinity: a [11C]raclopride positron emission tomography study in cats , 2004, Biological Psychiatry.

[131]  Mark Slifstein,et al.  Measurement of the Proportion of D2 Receptors Configured in State of High Affinity for Agonists in Vivo: A Positron Emission Tomography Study Using [11C]N-Propyl-norapomorphine and [11C]Raclopride in Baboons , 2005, Journal of Pharmacology and Experimental Therapeutics.

[132]  J. Tiihonen,et al.  Striatal dopamine D1 receptors in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography , 2005, Brain Research.

[133]  Ulla Ruotsalainen,et al.  Striatal D2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence , 1994, Psychopharmacology.

[134]  P. Seeman,et al.  L-DOPA reverses the elevated density of D2 dopamine receptors in Parkinson's diseased striatum , 2005, Journal of Neural Transmission.

[135]  N. Ginovart,et al.  Antiparkinson concentrations of pramipexole and PHNO occupy dopamine D2high and D3high receptors , 2005, Synapse.

[136]  Sylvain Houle,et al.  Binding characteristics and sensitivity to endogenous dopamine of [11C]‐(+)‐PHNO, a new agonist radiotracer for imaging the high‐affinity state of D2 receptors in vivo using positron emission tomography , 2006, Journal of neurochemistry.

[137]  L. Trudeau,et al.  Expression of D2 receptor isoforms in cultured neurons reveals equipotent autoreceptor function , 2006, Neuropharmacology.

[138]  Sidse Arnfred,et al.  Quantitative autoradiography of ligands for dopamine receptors and transporters in brain of Göttingen minipig: Comparison with results in vivo , 2006, Synapse.

[139]  W. McGuire Perinatal asphyxia. , 2012, Clinical evidence.

[140]  Christer Halldin,et al.  Effect of amphetamine on dopamine D2 receptor binding in nonhuman primate brain: A comparison of the agonist radioligand [11C]MNPA and antagonist [11C]raclopride , 2006, Synapse.

[141]  J. Holden,et al.  Sequential versus Nonsequential Measurement of Density and Affinity of Dopamine D2 Receptors with [11C]Raclopride: 2: Effects of DAT Inhibitors , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[142]  G. Muehllehner,et al.  Positron emission tomography , 2006, Physics in medicine and biology.

[143]  T. Sotnikova,et al.  Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. , 2006, CNS & neurological disorders drug targets.

[144]  M. Laruelle,et al.  [11C]NNC 112 Selectivity for Dopamine D1 and Serotonin 5-HT2A Receptors: A PET Study in Healthy Human Subjects , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[145]  Shitij Kapur,et al.  Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO , 2007, Synapse.

[146]  L. Minuzzi,et al.  Comparison of the binding distribution of agonist and antagonist ligands for histamine H3 receptors in pig brain by quantitative autoradiography. , 2007, European journal of pharmacology.

[147]  Evan D Morris,et al.  Positron Emission Tomography Displacement Sensitivity: Predicting Binding Potential Change for Positron Emission Tomography Tracers Based on Their Kinetic Characteristics , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[148]  Mark Slifstein,et al.  In Vivo DA D1 Receptor Selectivity of NNC 112 and SCH 23390 , 2007, Molecular Imaging and Biology.

[149]  B. Dean,et al.  Treatment with haloperidol and diazepam alters GABAA receptor density in the rat brain , 2008, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[150]  Ariel Graff-Guerrero,et al.  Brain region binding of the D2/3 agonist [11C]‐(+)‐PHNO and the D2/3 antagonist [11C]raclopride in healthy humans , 2008, Human brain mapping.

[151]  P. Seeman,et al.  Increase of dopamine D2High receptors in the striatum of rats sensitized to caffeine motor effects , 2008, Synapse.

[152]  P. Seeman,et al.  Phencyclidine and glutamate agonist LY379268 stimulate dopamine D2High receptors: D2 basis for schizophrenia , 2008, Synapse.

[153]  Alan A. Wilson,et al.  Dopamine D2 receptor radiotracers [(11)C](+)-PHNO and [(3)H]raclopride are indistinguishably inhibited by D2 agonists and antagonists ex vivo. , 2008, Nuclear medicine and biology.

[154]  T. Robinson,et al.  Cocaine self-administration produces a persistent increase in dopamine D2High receptors , 2008, European Neuropsychopharmacology.

[155]  E. London,et al.  Estimation of D2-like Receptor Occupancy by Dopamine in the Putamen of Hemiparkinsonian Monkeys , 2008, Neuropsychopharmacology.

[156]  Flemming Andersen,et al.  Evaluation of the Novel 5-HT4 Receptor PET Ligand [11C]SB207145 in the Göttingen Minipig , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[157]  Jaanus Harro,et al.  Rats with persistently high exploratory activity have both higher extracellular dopamine levels and higher proportion of D  2High receptors in the striatum , 2009, Synapse.

[158]  D. Sibley,et al.  Pharmacological characterization of 2‐methoxy‐N‐propylnorapomorphine's interactions with D2 and D3 dopamine receptors , 2009, Synapse.

[159]  M. Nader,et al.  Abstinence from Chronic Cocaine Self-Administration Alters Striatal Dopamine Systems in Rhesus Monkeys , 2009, Neuropsychopharmacology.

[160]  Mark Slifstein,et al.  In vivo quantification of regional dopamine‐D3 receptor binding potential of (+)‐PHNO: Studies in non‐human primates and transgenic mice , 2009, Synapse.

[161]  Christer Halldin,et al.  Dopamine D 2/3 Receptor Occupancy of Apomorphine in the Nonhuman Primate Brain—A Comparative PET Study With , 2022 .

[162]  Jouke Dijkstra,et al.  Changes in GABAA receptor properties in amygdala kindled animals: In vivo studies using [11C]flumazenil and positron emission tomography , 2009, Epilepsia.

[163]  P. Seeman,et al.  Dopamine D2High receptors stimulated by phencyclidines, lysergic acid diethylamide, salvinorin A, and modafinil , 2009, Synapse.

[164]  Alan A. Wilson,et al.  Ex vivo [11C]‐(+)‐PHNO binding is unchanged in animal models displaying increased high‐affinity states of the D2 receptor in vitro , 2009, Synapse.

[165]  M. Millan From the cell to the clinic: a comparative review of the partial D₂/D₃receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease. , 2010, Pharmacology & therapeutics.

[166]  Mark Slifstein,et al.  Impact of D2 Receptor Internalization on Binding Affinity of Neuroimaging Radiotracers , 2010, Neuropsychopharmacology.

[167]  Claus Svarer,et al.  Brain imaging of serotonin 4 receptors in humans with [11C]SB207145-PET , 2010, NeuroImage.

[168]  L. Mrzljak,et al.  D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]‐MNPA, [3H]‐(+)‐PHNO, and [3H]‐raclopride , 2010, Synapse.

[169]  L. Minuzzi,et al.  MDMA‐evoked changes in the binding of dopamine D2 receptor ligands in striatum of rats with unilateral serotonin depletion , 2010, Synapse.

[170]  Alan A. Wilson,et al.  Isoflurane Anaesthesia Differentially Affects the Amphetamine Sensitivity of Agonist and Antagonist D2/D3 Positron Emission Tomography Radiotracers: Implications for In Vivo Imaging of Dopamine Release , 2011, Molecular Imaging and Biology.

[171]  L. Minuzzi,et al.  Agonist binding fraction of dopamine D2/3 receptors in rat brain: A quantitative autoradiographic study , 2010, Neurochemistry International.

[172]  Sylvain Houle,et al.  Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925. , 2010, The international journal of neuropsychopharmacology.

[173]  F. Yasuno,et al.  Measurement of dopamine D2 receptors in living human brain using [11C]raclopride with ultra-high specific radioactivity. , 2010, Nuclear medicine and biology.

[174]  E. Stein,et al.  Effects of Early-Life Stress on Serotonin1A Receptors in Juvenile Rhesus Monkeys Measured by Positron Emission Tomography , 2010, Biological Psychiatry.

[175]  Jeih-San Liow,et al.  D2 dopamine receptor internalization prolongs the decrease of radioligand binding after amphetamine: A PET study in a receptor internalization-deficient mouse model , 2010, NeuroImage.

[176]  J. Lieberman,et al.  Characterization of in vivo Pharmacokinetic Properties of the Dopamine D1 Receptor Agonist DAR-0100A in Nonhuman Primates Using PET with [11C] NNC112 and [11C] Raclopride , 2011, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[177]  Mark Jenkinson,et al.  Imaging dopamine receptors in humans with [11C]-(+)-PHNO: Dissection of D3 signal and anatomy , 2011, NeuroImage.

[178]  Striatal D 2 dopamine receptor binding characteristics in vivo in patients with alcohol dependence , .